1 results match your criteria Pharmaceutical Development and Regulation[Journal]
Pharm Dev Regul 2003 Jan;1(3):191-203
US Department of Health and Human Services, National Institutes of Health, Office of Technology Transfer, Rockville, Maryland, USA.
Because technology licensed from research organizations can play a significant role in drug innovation and the generation of novel biomedical products, licensee performance under such agreements must be effectively monitored. This is necessary so that resultant benefits, including public health improvement, may be returned to the innovator(s) as well as society at large. The tasks that comprise monitoring are varied, but all come under the general heading of 'enforcement of license provisions'. Read More
Download full-text PDF